Business Standard

Torrent Pharmaceuticals Ltd News

Torrent Pharma Q1FY25 results: Net profit up 21%, revenue rises 10%

Revenues in the USA market, however, were down by 12 per cent at Rs 259 crore, falling from Rs 293 crore reported in Q1 FY24

Torrent Pharma Q1FY25 results: Net profit up 21%, revenue rises 10%
Updated On : 23 Jul 2024 | 6:49 PM IST

Torrent Pharma slips 3% after USFDA issues 5 observations for Indrad Unit

The fall came after the United States Food and Drug Administration (USFDA) issued a Form 483 with five observations for the Indrad unit

Torrent Pharma slips 3% after USFDA issues 5 observations for Indrad Unit
Updated On : 13 Jun 2024 | 11:05 AM IST

Torrent Group market capitalisation doubles to $20 billlion in one year

Diversified Torrent Group crossed USD 20 billion (Rs 1.68 lakh crore) in market capitalisation on Friday, nearly doubling the market value on the back of robust growth across businesses spanning from pharma to energy. Torrent Group had an m-cap of USD 10.8 billion (Rs 90,230 crore) on June 6, 2023. On Friday, two listed companies of the group, Torrent Pharmaceuticals Limited and Torrent Power Limited gained 2.22 per cent and 2.59 per cent, respectively, setting a new milestone for the group's market capitalisation at USD 20.2 billion at the close of market hours, according to stock exchange data. Shares of the group's flagship Torrent Pharmaceuticals ended at Rs 2,838 each and its arm Torrent Power closed at Rs 1,492.35 apiece on the NSE. Steady growth in the group's market capitalisation mirrors robust financial performance, sustained growth trajectory and business expansions across verticals. At the core of its growth strategy is the business model driven by acquisitions. The g

Torrent Group market capitalisation doubles to $20 billlion in one year
Updated On : 07 Jun 2024 | 10:36 PM IST

Pharma stocks in focus; Astrazeneca, Glenmark, Divi's, Torrent soar upto 9%

Torrent Pharma hits a new high of Rs 2,839.90, surging 9% in the intraday trade after the company reported a strong 56% Y-o-Y jump in Q4 profit

Pharma stocks in focus; Astrazeneca, Glenmark, Divi's, Torrent soar upto 9%
Updated On : 27 May 2024 | 11:35 AM IST

Torrent Pharma Q4FY24 results: Net profit up 57%, revenue rises 10%

At an operational level, Torrent Pharma's earnings before interest, tax, depreciation and amortisation (Ebitda) increased by 21 per cent to Rs 883 crore

Torrent Pharma Q4FY24 results: Net profit up 57%, revenue rises 10%
Updated On : 24 May 2024 | 7:24 PM IST

Torrent Pharma Q4 results: Net profit increases 56.45% to Rs 449 crore

Torrent Pharmaceuticals Ltd on Friday reported a 56.45 per cent jump in consolidated net profit to Rs 449 crore in the March quarter, riding on higher revenue. The company had posted a consolidated net profit of Rs 287 crore in the same period of the previous fiscal, Torrent Pharmaceuticals said in a regulatory filing. Consolidated revenue from operations in the fourth quarter of FY24 stood at Rs 2,745 crore as against Rs 2,491 crore in the year-ago period, it added. India revenue was at Rs 1,380 crore, up 10 per cent while the same for Brazil was at Rs 372 crore, registering a growth of 17 per cent, and Germany was at Rs 280 crore, up 11 per cent in the quarter, the company said. On the other hand, US business revenue was at Rs 262 crore, down 6 per cent, it added. Total expenses in the quarter under review was higher at Rs 2,145 crore as compared to Rs 2,067 crore in the same period a year ago. Torrent Pharma said its board has recommended a final dividend of Rs 6 per equity sh

Torrent Pharma Q4 results: Net profit increases 56.45% to Rs 449 crore
Updated On : 24 May 2024 | 7:15 PM IST

Torrent Pharma Q3 results: Profit after tax jumps 52% to Rs 443 cr

Torrent Pharmaceuticals on Friday reported a 52 per cent increase in its consolidated profit after tax to Rs 443 crore for the third quarter ended December 2023. The drug firm had reported a net profit of Rs 292 crore in the October-December period of the last fiscal. Its revenue increased by 10 per cent to Rs 2,732 crore in the third quarter compared to Rs 2,491 crore in the year-ago period, Torrent Pharmaceuticals said in a statement. The company said its domestic business revenues increased 12 per cent year-on-year to Rs 1,415 crore in the October -December quarter this year. Brazil's business grew by 26 per cent to Rs 312 crore, while the US business expanded by 6 per cent to Rs 274 crore in the third quarter. German revenues for the October-December period witnessed a 12 per cent growth to Rs 270 crore in the December 2023 quarter. Shares of the company on Friday ended 0.51 per cent up at Rs 2,524.70 apiece on the BSE.

Torrent Pharma Q3 results: Profit after tax jumps 52% to Rs 443 cr
Updated On : 02 Feb 2024 | 10:32 PM IST

Torrent Pharma Q3 results: Profit after tax up 51% at Rs 443 crore

Torrent Pharmaceuticals' share price rose by 0.51 per cent, ending the day's trade at Rs 2,524 apiece on the Bombay Stock Exchange (BSE)

Torrent Pharma Q3 results: Profit after tax up 51% at Rs 443 crore
Updated On : 02 Feb 2024 | 7:21 PM IST